EpiFix for diabetic foot ulcers

Press Release:*MiMedx® Group Announces Positive Results From Diabetic Foot Ulcer Randomized Controlled Trial*—Quote—MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane,… More..

Read more here:
EpiFix for diabetic foot ulcers

This entry was posted in Uncategorized and tagged , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *